AMI READMITS Score for 30-Day Readmission After Acute MI
Predicts 30-day all-cause readmission after acute myocardial infarction from seven variables available on the first day of admission (Nguyen 2018; derived in six Texas hospitals, not externally validated).
Score interpretation
READMITS ≤ 13: observed 30-day readmission 2% (predicted 3%).
→ Standard post-MI discharge plan: secondary prevention, cardiac rehabilitation referral, GP and cardiology follow-up.
READMITS 14–15: observed 8% (predicted 7%).
→ Standard post-MI discharge plan with medicines reconciliation and cardiac rehabilitation referral.
READMITS 16–17: observed 9% (predicted 11%).
→ Early follow-up after discharge; check understanding of medicines and warning symptoms.
READMITS 18–19: observed 17% (predicted 16%).
→ Target transitional care: early clinic review, pharmacist medicines reconciliation, follow-up call after discharge.
READMITS ≥ 20: observed 34% (predicted 35%).
→ Intensive transitional care: early review within days of discharge, community follow-up, flag on the discharge summary.
Interpretation bands for the READMITS Score. Apply clinical judgement and local guidance.
References
- Nguyen OK, Makam AN, Clark C, et al. Predicting 30-day hospital readmissions in acute myocardial infarction: the AMI "READMITS" score. J Am Heart Assoc. 2018;7(8):e008882.
- NICE NG185. Acute coronary syndromes. NICE. 2020.
Related
Curated clinical cross-links plus same-class fallbacks.
- Colchicine (Pericarditis / Post-MI Inflammation) · Pericarditis / Coronary Inflammation
- Lidocaine IV (Cardiac Arrhythmia) · Antiarrhythmic
- Lisinopril (HFrEF / Post-MI) · ACE Inhibitor / HFrEF
- Clopidogrel (ACS / Post-PCI) · Antiplatelet / ACS
- Glyceryl Trinitrate (Sublingual / IV) · Nitrate / Acute Angina
- Protamine Sulphate (Heparin Reversal) · Heparin Reversal / Cardiac Surgery
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.